InvestorsHub Logo
Followers 831
Posts 120032
Boards Moderated 17
Alias Born 09/05/2002

Re: md1225 post# 220399

Tuesday, 05/26/2015 8:45:55 AM

Tuesday, May 26, 2015 8:45:55 AM

Post# of 346073
[OT]—OCRX’s STOP-HE is considered a pivotal trial for the HE indication. So, it’s effectively a phase-3 even though listed on clincialtrials.gov as phase-2b.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News